Instituto de Investigaciones Clínicas para la Salud
Durango, Mexico
Medical clinic in Durango
Patoni, Prol Gómez Palacio Norte 404, 34000 Durango, Dgo.
About Instituto de Investigaciones Clínicas para la Salud
"¡Gracias por contactarnos!"
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Eli Lilly and Company
3
H. Lundbeck A/S
2
Sarepta Therapeutics, Inc.
2
Clinical Trials at Instituto de Investigaciones Clínicas para la Salud
During the past decade, Instituto de Investigaciones Clínicas para la Salud conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on
average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)
2016-09-28
2025-10-03
Active, not recruiting
229
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
2019-04-05
2030-12-18
Recruiting
190
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
2019-07-23
2023-12-06
Active, not recruiting
1,100
A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
2020-07-13
2024-11-30
Recruiting
154
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With sJIA
2020-02-12
2023-08-07
Recruiting
103
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
2021-07-16
2022-04-25
Completed
2,246
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
2021-06-30
2024-01-28
Recruiting
285
Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR).
2021-08-25
2022-07-25
Terminated
1,411
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Instituto de Investigaciones Clínicas para la Salud
According to Clinical.Site data, the most researched conditions in "Instituto de Investigaciones Clínicas para la Salud" are
"COVID-19" (4 trials), "Chronic Migraine in Children" (1 trials), "Crohn's Disease" (1 trials), "Duchenne Muscular Dystrophy" (1 trials) and "Juvenile Idiopathic Arthritis" (1 trials). Many other conditions were trialed in "Instituto de Investigaciones Clínicas para la Salud" in a lesser frequency.
Clinical Trials Intervention Types at Instituto de Investigaciones Clínicas para la Salud
Most popular intervention types in "Instituto de Investigaciones Clínicas para la Salud" are "Drug" (11 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Ritonavir" (4 trials), "PF-07321332" (3 trials), "Baricitinib" (2 trials) and "Eptinezumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Instituto de Investigaciones Clínicas para la Salud
The vast majority of trials in "Instituto de Investigaciones Clínicas para la Salud" are
9 trials for "All" genders and 2 trials for "Male" genders.
Clinical Trials Status at Instituto de Investigaciones Clínicas para la Salud
Currently, there are NaN active trials in "Instituto de Investigaciones Clínicas para la Salud".
undefined are not yet recruiting,
6 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Instituto de Investigaciones Clínicas para la Salud,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Instituto de Investigaciones Clínicas para la Salud, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".